Delivery Order SPE2DB22D9353-SPE2DB24FX1TD
Award Date 2/16/24
Potential Completion Date 3/11/24
Potential Value $40K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide KEYTRUDA 100 MG/4 ML VIAL 4ML. The order has a potential value of $80,285.70 and a completion date of February 8, 2024. DMS Pharmaceutical Group Inc. holds an indefinite delivery contract with DLA to supply a variety of pharmaceutical and medical products to support military treatment facilities globally. This specific order is delivered under...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Keytruda 100 mg/4 ml vials. The award, valued at $51,829.00, is part of a larger indefinite delivery contract (DLA contract 4600082013 under the SPE2DB program) with DMS Pharmaceutical Group that has a total potential value up to $4,999,999 through 2025. This contract vehicle enables the DLA to issue delivery orders...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product KEYTRUDA 100 MG/4 ML VIAL 4ML. The contract has a completion date of January 30, 2024 and a potential value of $24,065.52. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles with DLA to supply a variety of prescription...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide KEYTRUDA 100 MG/4 ML VIAL 4ML. The $116,257.80 contract has a period of performance through January 31, 2023 and is not set-aside. DMS Pharmaceutical Group holds multiple contracts and indefinite delivery vehicles with DLA Troop Support Medical to supply a variety of pharmaceutical and medical products in support of military...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide 4,564,751,606 units of Keytruda 100 mg/4 mL vial. The firm-fixed-price contract, valued at $80,218.40, runs through June 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which was awarded by the DLA to fulfill the recurring...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,563,469,465 units of the pharmaceutical product KEYTRUDA 100 MG/4 ML VIAL 4ML. The contract has a completion date of February 12, 2024 and a potential value of $80,218.40. This delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to provide various pharmaceutical and medical supplies...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $40,109.20 contract is for the supply of Keytruda 100 mg/4 ml vial (4 ml) to support the medical needs of military healthcare facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, that allows...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide KEYTRUDA 100 MG/4 ML VIAL 4ML. The order has a potential value of $80,285.70 and a completion date of February 8, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that supports the Department of Defense with a wide range of brand and generic prescription and over-the-counter drug supplies. This delivery order is part...
- The U.S. government agency Medical Supply Chain, part of the Department of Defense, awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Keytruda 100 mg/4 ml vial. The fixed-price contract is valued at $80,285.70 and has a term ending on March 29, 2024. This award is associated with a larger indefinite delivery contract (SPE2DB) that DMS Pharmaceutical Group holds with the Defense Logistics Agency, valued at up to $4,999,999...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Keytruda (pembrolizumab) 100 mg/4 mL vials. The contract, valued at $80,218.40, has an ultimate completion date of October 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA under the SPE2DB program, which has a ceiling value...